The company believes this new manufacturing facility will contribute to the growing Bitterroot biotech corridor, while ...
Rua Bioscience Limited (NZX: RUA) ('Rua”) and PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) ('PharmAla”) announce that Rua and PharmAla Biotech Inc., a subsidiary of PharmAla, have signed ...
For over a year, German officials have obstructed one of the Trump administration’s most important reform initiatives. And ...
Ipca Laboratories has proposed ₹1,080 crore investment in Dewas and Ujjain, with the projects expected to create around 1,500 ...
On Thursday, Biofrontera Inc. (BFRI) said it has submitted a supplemental New Drug Application (sNDA) to the U.S. FDA seeking to expand the approved use of Ameluz in combination with photodynamic ...
Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a precision guided, biotech/life sciences company focused on ...
Rocket Pharmaceuticals Inc. announced that it has entered into a credit facility agreement with Hercules Capital Inc. for up to $150 million.
InvestorsHub on MSN
X4 Pharmaceuticals secures up to $150 million in new debt financing from K2 HealthVentures
X4 Pharmaceuticals (NASDAQ:XFOR) has entered into a senior secured term loan agreement worth up to $150 million with K2 HealthVentures LLC, refinancing its existing debt facility and providing ...
Iambic Therapeutics is aiming for a $135 million IPO in net proceeds as the AI biotech looks to fund the clinical development ...
WASHINGTON — A broad tariff on imported pharmaceuticals took effect at the end of September, and some biopharma companies and ...
C-suite leaders from global industry giants including Illumina, Novartis, Thermo Fisher Scientific and Bristol Myers Squibb confirmed to speak in ...
PhRMA sues HHS; DOJ says it will crack down on fraud in pharma industry; Healthcare job growth outpaces other industries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results